Arvinas Inc.
Clinical-stage biopharmaceutical company pioneering the development of PROTAC (proteolysis targeting chimera) protein degraders for the treatment of cancer and other diseases.
Website
https://www.arvinas.comLocation
New Haven, Connecticut, USA
Founded
2013
Investors
1
Categories
biotech, protein-degradation, PROTAC, oncology, therapeutics
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| 5AM Ventures | Menlo Park, USA | biotech-focused | seedseries-a+1 | 8 |